Delineate vs Isomorphic Labs
Side-by-side comparison of features, pricing, and ratings
At a glance
| Dimension | Delineate | Isomorphic Labs |
|---|---|---|
| Pricing | Freemium (free tier + Professional plan from $XX/mo) | Contact-based (enterprise partnerships only) |
| Target Users | Clinical researchers, biostatisticians, operations managers | Large pharma companies, multi-billion dollar programs |
| Key Technology | Multi-agent AI for clinical trial design | AlphaFold-based Drug Design Engine (predictive + generative) |
| Deployment | SaaS, export to Word/PDF/CDISC, API on Professional plan | Deep collaboration model (not a product); no standalone API |
| Integrations | Medidata Rave, Veeva Vault, TrialMaster, OpenClinica, REDCap, SAS, RStudio, PubMed | None documented (operates via partnerships) |
| Recent Milestones | April 2026: Professional plan with API and custom agents | Feb 2026: Series B; Jan 2026: J&J collaboration; 2025: $600M funding |
If you need to create clinical trial protocols faster with compliance and integration into eClinical platforms, Delineate is the clear choice. Isomorphic Labs is for large pharma seeking AI-driven drug discovery partnerships—not a tool you can buy off the shelf. Choose based on your stage: protocol authoring (Delineate) vs. molecule design (Isomorphic).
What real users say: Delineate vs Isomorphic Labs
Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.
Delineate
36 mentions across 2 sources · 55% positive — mixed
Hacker News, Lemmy
What users praise
- • Multi-agent architecture automates distinct trial design tasks.
- • Focus on regulatory compliance (FDA, EMA, ICH) saves time.
- • Pre-built templates for oncology, neurology, rare diseases.
- • Generates export-ready protocols in Word, PDF, CDISC SDTM.
What frustrates them
- • Community feedback virtually non-existent; tool unproven in real use.
- • No integration details provided for eClinical tool connectivity.
- • Unclear if AI suggestions are accurate for complex endpoints.
- • Freemium pricing model may limit features for serious research.
Researched Jul 3, 2026
Isomorphic Labs
46 mentions across 3 sources · 73% positive
Hacker News, YouTube, Lemmy
What users praise
- • Backed by DeepMind's AlphaFold legacy and Nobel-winning science.
- • Massive pharma partnerships: Novartis, J&J, Eli Lilly.
- • Drug Design Engine (July 2026) moves beyond structure prediction.
- • Generative AI for molecule design, simulating drug behavior.
What frustrates them
- • Not a self-serve tool; partnership-only model limits access.
- • CASP16 shows no clear advantage over older prediction methods.
- • Clinical outcomes unproven; no approved drugs yet.
- • Returns tied to performance milestones, uncertain timeline.
Researched Aug 26, 2026
Who should pick which
- Clinical research associate at a mid-size CROPick: Delineate
Delineate's protocol generation, feasibility assessments, and CDISC export directly streamline their daily workflow, and the integrations with Medidata and Veeva fit their existing tech stack.
- Biostatistician designing adaptive trialsPick: Delineate
Delineate offers adaptive trial design templates (Bayesian dose-finding) and endpoint selection rationale, reducing manual statistical work.
- VP of R&D at a large pharma companyPick: Isomorphic Labs
For early-stage drug discovery targeting novel protein targets, Isomorphic Labs' Drug Design Engine and AlphaFold expertise provide a competitive edge — but only through a partnership, not a product.
- Regulatory affairs specialistPick: Delineate
Delineate's regulatory compliance checklists (FDA, EMA, ICH) and protocol summaries match their compliance needs, plus they can export to submission-ready formats.
- Small biotech startup without pharma partnershipsPick: Delineate
Isomorphic Labs is inaccessible to them due to high entry cost and partnership model. Delineate's freemium pricing and no-code custom agents allow them to accelerate trial design on a budget.
Frequently Asked Questions
Delineate vs Isomorphic Labs: which should you choose?
If you need to create clinical trial protocols faster with compliance and integration into eClinical platforms, Delineate is the clear choice. Isomorphic Labs is for large pharma seeking AI-driven drug discovery partnerships—not a tool you can buy off the shelf. Choose based on your stage: protocol authoring (Delineate) vs. molecule design (Isomorphic).
Can I use Isomorphic Labs as a standalone software or API?
No. Isomorphic Labs operates solely through deep pharma partnerships (e.g., Novartis, Johnson & Johnson). There is no public API or self-service product.
Does Delineate integrate with my existing EDC system?
Yes. Delineate integrates with Medidata Rave EDC, Veeva Vault Clinical, TrialMaster, OpenClinica, and REDCap, plus tools like SAS, RStudio, PubMed, and ClinicalTrials.gov.
Is Delineate suitable for rare disease trials?
Yes. Delineate includes rare disease agent workflows that leverage natural history comparisons, which is critical for small patient populations.
What pricing models do these tools offer?
Delineate is freemium — free tier and Professional plan (pricing undisclosed). Isomorphic Labs is contact-only; no published pricing.
Which tool is better for regulatory compliance?
Delineate provides compliance checklists for FDA, EMA, and ICH, and exports to CDISC SDTM. Isomorphic Labs does not offer compliance features — it focuses on early discovery.
Has Isomorphic Labs released a new product recently?
No. The latest news (2026-05-12) is a Series B investment; no product launch. Their Drug Design Engine remains partnership-only.
Can I generate a full protocol outline with Delineate?
Yes. Delineate's multi-agent AI generates protocol outlines, endpoint selection rationale, feasibility reports, and literature synthesis — reducing creation time from weeks to minutes.
Do these tools compete in the same space?
Not directly. Delineate targets clinical trial design and operations (Phase I-IV). Isomorphic Labs targets early drug discovery (target identification, lead optimization).
More Delineate or Isomorphic Labs comparisons
Angle and Isomorphic Labs serve completely different domains—Angle is a free, niche pose-measurement tool for fitness professionals, while Isomorphic Labs is an enterprise AI drug discovery platform f
These tools serve completely different markets. CalBye is a consumer nutrition app for individuals wanting effortless calorie tracking via photos, while Isomorphic Labs is an enterprise drug discovery
Choose Ray if you need an adaptive, low-barrier AI personal trainer for flexible, voice-guided workouts — it's ideal for busy individuals wanting consistency without gym intimidation. Choose Isomorphi
These tools are polar opposites in audience and purpose. Ironclaw AI Vision is a free, offline-first PWA for individual fitness tracking with AI coaching and meal planning – ideal for privacy-consciou
Isomorphic Labs and Swimio serve completely different worlds: one is a high-stakes pharma AI platform for billion-dollar drug programs, the other a consumer fitness app for swimmers. Choose based on y
MediSphere and Isomorphic Labs serve completely different healthcare verticals. Choose MediSphere if you run a small clinic needing AI-powered administration, no-show prediction, and EHR. Choose Isomo
Explore each tool further
Browse these categories
One email a week — new tools, honest comparisons, no spam.
Last reviewed: July 3, 2026